Introducing the Dual Prevention Pill: Lessons Learned and What’s Next for Regulatory, Research, and Rollout
The Dual Prevention Pill (DPP) is the most advanced multipurpose prevention technology (MPT) currently in development, combining HIV prevention and contraception in one daily pill. In this webinar, we’ll explore the product pipeline, outline the regulatory pathway, and highlight the implementation agenda that lies ahead. With presenters including Kate Segal (AVAC), Wawira Nyagah (AVAC), and Barbara Friedland (Population Council).
View Webinar Recording
Download Presentation-DPP Acceptability Studies
Download Presentation-DPP RD and Regulatory
September 2025
Click for full info +Full Info:
Resource Type:
Citation:
The Dual Prevention Pill (DPP) is the most advanced multipurpose prevention technology (MPT) currently in development, combining HIV prevention and contraception in one daily pill. In this webinar, we explore the product pipeline, outline the regulatory pathway, and highlight the implementation agenda that lies ahead. With presenters including Kate Segal (AVAC), Wawira Nyagah (AVAC), and Barbara Friedland (Population Council).
Authors: Kate Segal (AVAC), Wawira Nyagah (AVAC), and Barbara Friedland (Population Council), The IMPT
Health Risks(s):
- HIV
- Unintended Pregnancy
Product type(s):
- MPTs
Topic(s):
- MPTs
- Development
Region(s)
- Global